Alpha Genesis Inc. is a leading primate research specialist company established in 2003, headquartered in the United States. The company offers top-quality nonhuman primate products and bio-research services globally. Alpha Genesis Inc. serves various industries, including Biopharma, Biotechnology, Health Care, and Pharmaceutical. The company recently received a $2.00M debt financing investment on 01 February 2022. The Alpha Genesis Primate Research Center provides a comprehensive range of services such as Nonhuman Primates for Biomedical Research, Contract Research and Consultation, Primate Housing and CDC Quarantine, and Biological Products and Materials. Its research areas of focus encompass Aging and Metabolic Diseases, Immunogenetics and Immunology, Reproduction, Neurobiology, Physiological Ethology, and Psychobiology. Recent research has centered on critical areas like embryonic stem cells, AIDS vaccine research, women's health, developmental disorders, glaucoma and presbyopia, osteoporosis, Parkinson's, movement disorders, diabetes, drug addiction, and obesity. Alpha Genesis Inc. stands out for offering primate veterinary training in biology, medicine, biomedical research, and behavior, providing a unique opportunity to directly work with monkeys. The company also supports educational opportunities for students, accepting research plans from interested applicants. With an emphasis on customer service, the company aims to provide the best and most cost-effective research and development support. The highly qualified employees at Alpha Genesis Inc.'s facilities are dedicated to delivering superior service. For inquiries or orders, interested parties can reach out to Alpha Genesis Inc. via email at [email protected] or by calling toll-free at 866.789.MONK (6665). Further information can be found on their websites www.alphagenesisinc.com and www.primateresearch.com.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Corporate Round | $2.50M | - | 01 Nov 2021 | |
Corporate Round | $1.00M | - | 30 Dec 2020 | |
Funding Round | $4.60M | 1 | National Institutes of Health | 12 Jun 2020 |
Venture Round | $1.50M | - | 05 Dec 2019 | |
Funding Round | $1.25M | - | 26 Nov 2019 |
No recent news or press coverage available for Alpha Genesis Inc..